BELLEVICINE, CLAUDIO
 Distribuzione geografica
Continente #
NA - Nord America 2.194
EU - Europa 1.342
AS - Asia 1.203
AF - Africa 36
SA - Sud America 17
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 4.795
Nazione #
US - Stati Uniti d'America 2.157
IT - Italia 732
SG - Singapore 556
HK - Hong Kong 293
CN - Cina 284
NL - Olanda 130
RU - Federazione Russa 128
FI - Finlandia 102
DE - Germania 85
IE - Irlanda 76
CI - Costa d'Avorio 35
CA - Canada 33
GB - Regno Unito 23
IN - India 23
VN - Vietnam 18
IR - Iran 14
ES - Italia 12
BR - Brasile 11
PL - Polonia 8
UA - Ucraina 8
AT - Austria 7
FR - Francia 7
AR - Argentina 5
BE - Belgio 4
CZ - Repubblica Ceca 4
MX - Messico 4
RS - Serbia 4
PK - Pakistan 3
RO - Romania 3
SE - Svezia 3
TR - Turchia 3
EU - Europa 2
JP - Giappone 2
PT - Portogallo 2
AU - Australia 1
AZ - Azerbaigian 1
BG - Bulgaria 1
EE - Estonia 1
EG - Egitto 1
HR - Croazia 1
IL - Israele 1
KR - Corea 1
LT - Lituania 1
NP - Nepal 1
OM - Oman 1
PE - Perù 1
PH - Filippine 1
TW - Taiwan 1
Totale 4.795
Città #
Chandler 427
Singapore 393
Hong Kong 291
Naples 165
Millbury 137
Santa Clara 132
Napoli 120
Amsterdam 117
Ashburn 99
Des Moines 78
Princeton 71
Beijing 67
Nanjing 62
Boston 53
Lawrence 51
Wilmington 46
Helsinki 33
Ottawa 29
Rome 29
Nanchang 24
Hebei 21
Milan 21
San Giovanni Rotondo 19
Seattle 19
Dong Ket 16
Los Angeles 14
Munich 14
Jiaxing 13
Falls Church 12
Redwood City 12
Salerno 12
Changsha 10
Falkenstein 10
Tehran 10
Valencia 10
Dallas 9
Dublin 9
Nuremberg 9
Shenyang 9
Pune 8
Tianjin 8
Warsaw 8
Woodbridge 8
Lappeenranta 7
Santa Maria 7
Viareggio 7
Fairfield 6
Messina 6
Campagna 5
Caserta 5
Guangzhou 5
Houston 5
Jacksonville 5
Pagani 5
Shanghai 5
Belgrade 4
Chieti 4
Frankfurt am Main 4
Norwalk 4
Pomigliano d'Arco 4
Toronto 4
Villaricca 4
Washington 4
Ardabil 3
Arielli 3
Bologna 3
Brusciano 3
Caivano 3
Florence 3
Grosseto 3
Karachi 3
Lanzhou 3
London 3
Marigliano 3
Nocera Superiore 3
Portici 3
Pozzuoli 3
Redmond 3
Ronco all'Adige 3
Salt Lake City 3
Torre del Greco 3
Vienna 3
Afragola 2
Alba 2
Alges 2
Augusta 2
Avellino 2
Aversa 2
Bagnoli Irpino 2
Brindisi 2
Brussels 2
Buenos Aires 2
Casapulla 2
Cava De' Tirreni 2
Cava de' Tirreni 2
Cernobbio 2
Cipolletti 2
Council Bluffs 2
Coyoacán 2
Edinburgh 2
Totale 2.898
Nome #
Performance analysis of SiRe next-generation sequencing panel in diagnostic setting: focus on NSCLC routine samples 102
Generation and analysis of spheroids from human primary skin myofibroblasts: an experimental system to study myofibroblasts deactivation 81
SMO Gene Amplification and Activation of the Hedgehog Pathway as Novel Mechanisms of Resistance to Anti-Epidermal Growth Factor Receptor Drugs in Human Lung Cancer 80
Analysis of human primary fibroblast spheroids 75
Development of a Stromal Microenvironment Experimental Model Containing Proto-Myofibroblast Like Cells and Analysis of Its Crosstalk with Melanoma Cells: A New Tool to Potentiate and Stabilize Tumor Suppressor Phenotype of Dermal Myofibroblasts 68
Discordance in RAS mutations between primary colon tumor and metastases: a real event or a matter of methodology? 67
Type 2 Deiodinase Thr92Ala Polymorphism and Aging Are Associated with a Decreased Pituitary Sensitivity to Thyroid Hormone 65
The Metallophosphoesterase-Domain-Containing Protein 2 (MPPED2) Gene Acts as Tumor Suppressor in Breast Cancer 64
Combination of Lenvatinib and Pembrolizumab as Salvage Treatment for Paucicellular Variant of Anaplastic Thyroid Cancer: A Case Report 61
Impairment of T cell development and acute inflammatory response in HIV-1 Tat transgenic mice 60
Less frequently mutated genes in colorectal cancer: Evidences from next-generation sequencing of 653 routine cases 59
Development of a gene panel for next-generation sequencing of clinically relevant mutations in cell-free DNA from cancer patients 56
ALK and ROS1 testing on lung cancer cytologic samples: Perspectives 56
Cell free DNA analysis by SiRe® next generation sequencing panel in non small cell lung cancer patients: focus on basal setting. 56
Thyroid Cancer and Fibroblasts 53
UbcH10 expression can predict prognosis and sensitivity to the antineoplastic treatment for colorectal cancer patients 53
Evaluation of BRAF, RAS, RET/PTC, and PAX8/PPARg alterations in different Bethesda diagnostic categories: A multicentric prospective study on the validity of the 7-gene panel test in 1172 thyroid FNAs deriving from different hospitals in South Italy 53
Predictive molecular pathology in metastatic thyroid cancer: the role of RET fusions 52
Foxe1 gene dosage affects thyroid cancer histology and differentiation in vivo 51
Next-Generation Sequencing of Lung Cancer EGFR Exons 18-21 Allows Effective Molecular Diagnosis of Small Routine Samples (Cytology and Biopsy). 49
EGFR mutations detected on cytology samples by a centralized laboratory reliably predict response to gefitinib in non-small cell lung carcinoma patients. 49
The continuing role of breast fine-needle aspiration biopsy after the introduction of the IAC Yokohama System For Reporting Breast Fine Needle Aspiration Biopsy Cytopathology 49
CD10 is useful to identify gastrointestinal contamination in endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) cytology from pancreatic ductal adenocarcinoma. 48
Different qualifiers of AUS/FLUS thyroid FNA have distinct BRAF, RAS, RET/PTC, and PAX8/PPARg alterations. 48
UbcH10 overexpression in human lung carcinomas and its correlation with EGFR and p53 mutational status. 47
Bird's eye view of modern cytopathology: Report from the seventh international Molecular Cytopathology Meeting in Naples, Italy, 2018 47
Moving towards a local testing solution for undetermined thyroid fine-needle aspirates: validation of a novel custom DNA-based NGS panel 47
PD-L1 expression in cell-blocks of non-small cell lung cancer: The impact of prolonged fixation 46
Evaluation of the Molecular Landscape in PD-L1 Positive Metastatic NSCLC: Data from Campania, Italy 45
Pure primary squamous cell carcinoma of the breast presenting as an intracystic tumor. 45
KRAS Mutant Allele Specific Imbalance (MASI) assessment in routine samples of metastatic colorectal cancer patients 45
Challenges and opportunities of next-generation sequencing: a cytopathologist's perspective 45
Role of Cytomorphology in the Era of Liquid Biopsy 45
EGFR mutant allelic-specific imbalance assessment in routine samples of non-small cell lung cancer 43
Cytopathologists can reliably perform ultrasound-guided thyroid fine needle aspiration: a 1-year audit on 3715 consecutive cases 43
UbcH10 overexpression is less pronounced in older colorectal cancer patients 43
Ion Torrent next-generation sequencing for routine identification of clinically relevant mutations in colorectal cancer patients 42
Microfluidic chip technology applied to fine-needle aspiration cytology samples for IGH clonality assessment 42
Is the Idylla EGFR Mutation Assay feasible on archival stained cytological smears? A pilot study 42
Long-term management of lenvatinib-treated thyroid cancer patients: a real-life experience at a single institution 42
Herbal hepatotoxicity: a case of difficult interpretation. 41
Cytological and Molecular Features of PapillaryThyroid Carcinoma with Prominent Hobnail Features:A Case Report 41
EGFR mutation detection on lung cancer cytological specimens by the novel fully automated PCR-based Idylla EGFR Mutation Assay 41
Biopsic Sampling (cancer) comprehensive sampling and sample preparation 40
EGFR mutation detection by microfluidic technology: a validation study. 40
Performance of EGFR mutant-specific antibodies in different cytological preparations: a validation study 40
Fully automated PCR detection of KRAS mutations on pancreatic endoscopic ultrasound fine-needle aspirates 40
Consistency and reproducibility of next-generation sequencing and other multigene mutational assays: A worldwide ring trial study on quantitative cytological molecular reference specimens 39
Circulating tumour cells in predictive molecular pathology: Focus on drug-sensitive assays and 3D culture 39
Rapid On-site Molecular Evaluation in thyroid cytopathology: A same-day cytological and molecular diagnosis 39
Impact assessment of the implementation of an integrated care model for thyroid disease at the university hospital “federico ii” of naples (Campania region, southern italy): An interrupted time series analysis 39
Brca1/2 ngs somatic testing in clinical practice: a short report 39
A Roadmap for a Comprehensive Diagnostic Approach to Fine Needle Cytology of Lymph Node Metastases 38
EGFR analysis: Current evidence and future directions 38
Next-generation sequencing in the genomic profiling of synchronous colonic carcinomas: comment on Li et al (2015) 38
RNA-Based Assay for Next-Generation Sequencing of Clinically Relevant Gene Fusions in Non-Small Cell Lung Cancer 38
EGFR mutation detection on routine cytological smears of non-small cell lung cancer by digital PCR: A validation study 37
Multiplex digital colour-coded barcode technology on RNA extracted from routine cytological samples of patients with non-small cell lung cancer: pilot study 37
Potential involvement of neutrophils in human thyroid cancer 37
Consistency and reproducibility of next-generation sequencing in cytopathology: A second worldwide ring trial study on improved cytological molecular reference specimens 37
Liquid Biopsy in Prostate Cancer Management{\textemdash}Current Challenges and Future Perspectives 36
Cytologically undetermined follicular lesions: surgical procedures and histological outcome in 472 cases. 36
EGFR exon 19 deletion switch and development of p.L792Q mutation as a new resistance mechanism to osimertinib: A case report and literature review 36
Predictive molecular pathology in the time of COVID-19 36
Cytology in the time of coronavirus disease (covid-19): An Italian perspective 36
Thyroid fine-needle aspiration trends before, during, and after the lockdown: what we have learned so far from the COVID-19 pandemic 36
Methods for actionable gene fusion detection in lung cancer: now and in the future 36
KRAS testing in metastatic colorectal carcinoma: challenges, controversies, breakthroughs, and beyond 35
Applications and limitations of oncogene mutation testing in clinical cytopathology. 35
How should a follicular adenoma with papillary architecture be classified on thyroid FNA? Case report with histological correlation 35
Lung adenocarcinoma and its thyroid metastasis characterized on fine-needle aspirates by cytomorphology, immunocytochemistry, and next-generation sequencing 35
KRAS mutations testing in non-small cell lung cancer: The role of Liquid biopsy in the basal setting 35
Cytopathology practice during the COVID-19 postlockdown: An Italian experience 35
COVID-19 pandemic impact on cytopathology practice in the post-lockdown period: An international, multicenter study 35
Fine-needle aspiration findings in focal (nodular) myositis of a newborn: A case report 33
Molecular Testing of Thyroid Fine-Needle Aspiration: Local Issues and Solutions. An Interventional Cytopathologist Perspective 33
Next generation sequencing in cytology 33
Multicentric encapsulated papillary oncocytic neoplasm of the thyroid: A case diagnosed by a combined cytological, histological, immunohistochemical, and molecular approach 32
Foamy gland pancreatic ductal adenocarcinoma diagnosed on EUS-FNA: A histochemical, immunohistochemical, and molecular report 32
Ciliated foregut cyst of the pancreas: A benign lesion with elevated CEA levels 32
Next generation sequencing techniques in liquid biopsy: focus on non-small cell lung cancer patients 32
Young investigator challenge: Can the Ion AmpliSeq Cancer Hotspot Panel v2 be used for next-generation sequencing of thyroid FNA samples? 32
Evaluation of Micro Satellite Instability and Mismatch Repair Status in Different Solid Tumors: A Multicenter Analysis in a Real World Setting 32
Fine-Needle Aspiration Is Suitable for Breast Cancer BRCA Molecular Assessment: A Case Report 32
PD-L1 and beyond: Immuno-oncology in cytopathology 32
There is still a role for cytology in the 'liquid biopsy' era. A lesson from a TKI-treated patient showing adenocarcinoma to squamous cell carcinoma transition during disease progression 31
PD-L1 expression on routine samples of non-small cell lung cancer: Results and critical issues from a 1-year experience of a centralised laboratory 31
Approach to cytological indeterminate thyroid nodules 31
Cytopathology Practice in the COVID-19 Era: Focus on Sample Workload 31
KRAS mutation detection by high resolution melting analysis significantly predicts clinical benefit of cetuximab in metastatic colorectal cancer 30
Ultimobranchial body remnants (solid cell nests) as a pitfall in thyroid pathology. 30
Is the Isthmus Location an Additional Risk Factor for Indeterminate Thyroid Nodules? Case Report and Review of the Literature. 30
RNA-based next generation sequencing in non-small-cell lung cancer in a routine setting: an experience from an Italian referral center 29
SANGER SEQUENCING IN ROUTINE KRAS TESTING: AREVIEW OF 1720 CASES FROM A PATHOLOGIST’SPERSPECTIVE 29
Morphological and immunocytochemical features of Merkel cell carcinoma metastatic to the pancreas diagnosed by endoscopic ultrasound-guided fine-needle aspiration 29
Tissue Microarray from Cell Block Material (cbTMA)—An Additional Shot for Cytology in the Predictive Pathology Era: The PD-L1 Experience 29
Microsatellite instability evaluation of patients with solid tumour: routine practice insight from a large series of Italian referral centre 29
Thyroid Carcinoma: Molecular Signature by Histotype-Specific Mutations and Gene Expression Patterns Diagnostic, Prognostic and Therapeutic Value of Gene Signatures 28
Kras Testing On Cytologic Imprints of Colo-rectal Carcinoma 27
Effects of combined administration of rapamycin, tolvaptan, and AEZ-131 on the progression of polycystic disease in PCK rats 27
Totale 4.235
Categoria #
all - tutte 25.897
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.897


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020180 0 0 0 0 0 0 0 72 1 34 60 13
2020/2021207 8 1 8 8 9 44 18 24 32 24 12 19
2021/2022754 12 13 8 11 9 16 14 43 78 63 172 315
2022/20231.101 131 56 41 83 142 118 5 118 201 123 65 18
2023/2024730 39 137 91 48 30 50 6 88 23 33 106 79
2024/20251.428 199 235 8 23 114 213 437 199 0 0 0 0
Totale 5.088